Sort
50,496 grants matching “lung cancer”
Gene Methylation and Therapeutic Response in Lung Cancer
$655,842Lovelace Biomedical &Environmental Res · R01 · FY2005 · CA
Development of antibacterial agents and materials
$655,823Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Adenocarcinoma of the Lung: role of NNK susceptibility
$655,751Margaret R Spitz · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer Agent
$655,747Seth J Field · Case Western Reserve University · R01 · FY2022 · CA
Collaborative Protein Technology Resource: Automated Capillary Immunoassays
$655,710Jinqiu Chen · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Understanding efficacy and FE(II)-Promoted Activation of 1,2,4-Trioxolanes in cancer
$655,693Eric Collisson · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Electronic Cigarette-derived Oxidants and their Impact on Lung Cancer Development
$655,675John P Richie · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2020 · CA
Biomarkers to Assess Selenium Chemoprevention for NSCLC
$655,631Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2007 · CA
Human Molecular Genetics of Vascular Disease
$655,557David J. Pinsky · University Of Michigan At Ann Arbor · P30 · FY2010 · HL
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
$655,529Katerina Abigail Politi · Yale University · R01 · FY2022 · CA
Investigating the therapeutic potential of a novel glutamine antagonist in KEAP1 mutant lung cancer
$655,478Thales Papagiannakopoulos · New York University School Of Medicine · R01 · FY2025 · CA
Oral Microbiome and Lung Cancer Risk
$655,290Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2018 · CA
Randomized Clinical Trial of Lung Cancer Chemoprevention with Sulforaphane in Former Smokers
$655,278Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension
$655,252Ruslan Rafikov · Indiana University Indianapolis · R01 · FY2024 · HL
Disparities in access to and outcomes of cancer surgery for rural Medicare patients
$655,190Anna N. A. Tosteson · Dartmouth College · R01 · FY2021 · CA
Urinary cadmium and risk of breast cancer
$655,188Jaymie R Meliker · State University New York Stony Brook · R01 · FY2014 · ES
Improving smoking abstinence outcomes in the African American community through extended treatment
$655,179Lisa Sanderson Cox · University Of Kansas Medical Center · R01 · FY2022 · CA
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
$655,170Evan Michael Graboyes · Medical University Of South Carolina · R01 · FY2024 · CA
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
$655,149Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AR
Venous Thrombosis in Cancer Outpatients: Prevention and Role of Tissue Factor
$655,109Charles W. Francis · University Of Rochester · R01 · FY2011 · HL
The role of complement proteins in cardiovascular disease
$655,023Akira Takashima · University Of Toledo Health Sci Campus · P30 · FY2009 · HL
Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol
$654,995Mokenge P. Malafa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer
$654,948Pierre P Massion · Vanderbilt University · U01 · FY2012 · CA
CAREER: Rational Design of Efficient Carbon Nanotube-Supported TiO2 Photocatalysts for Air Purification
$654,870Placidus B Amama · Kansas State University · · FY2017 · ENG
Mechanisms of tumorigenesis in Brg1 mutant lung cancer
$654,799Carla F. Kim · Boston Children'S Hospital · R01 · FY2020 · CA